Identification of cross-reactive allergens in cashew- and pistachio-allergic children during oral immunotherapy.
He, Z; Dongre, P; Lyu, S; Manohar, M; Chinthrajah, RS; Galli, SJ; DeKruyff, RH; Nadeau, KC; Andorf, S.
Pediatric Allergy and Immunology.
2020;
31:709-714.
Mass cytometry reveals cellular fingerprint associated with IgE plus peanut tolerance and allergy in early life.
Neeland, MR; Andorf, S; Manohar, M; Dunham, D; Lyu, S; Dang, TD; Peters, RL; Perrett, KP; Tang, ML K; Saffery, R; et al.
Nature Communications.
2020;
11.
Global metabolic profiling to model biological processes of aging in twins.
Bunning, BJ; Contrepois, K; Lee-McMullen, B; Dhondalay, GK R; Zhang, W; Tupa, D; Raeber, O; Desai, M; Nadeau, KC; Snyder, MP; et al.
Aging Cell.
2020;
19.
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals.
Andorf, S; Purington, N; Kumar, D; Long, A; O'Laughlin, KL; Sicherer, S; Sampson, H; Cianferoni, A; Whitehorn, TB; Petroni, D; et al.
EClinicalMedicine.
2019;
7:27-38.
MetaCyto: A Tool for Automated Meta-analysis of Mass and Flow Cytometry Data.
Hu, Z; Jujjavarapu, C; Hughey, JJ; Andorf, S; Lee, H; Gherardini, PF; Spitzer, MH; Thomas, CG; Campbell, J; Dunn, P; et al.
Cell Reports.
2018;
24:1377-1388.
Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.
Andorf, S; Purington, N; Block, WM; Long, AJ; Tupa, D; Brittain, E; Spergel, AR; Desai, M; Galli, SJ; Nadeau, KC; et al.
The Lancet Gastroenterology and Hepatology.
2018;
3:85-94.
Association of Clinical Reactivity with Sensitization to Allergen Components in Multifood-Allergic Children.
Andorf, S; Borres, MP; Block, W; Tupa, D; Bollyky, JB; Sampath, V; Elizur, A; Lidholm, J; Jones, JE; Galli, SJ; et al.
Journal of Allergy and Clinical Immunology-In Practice.
2017;
5:1325-1334.e4.
Reduced polyfunctional T cells and increased cellular activation markers in adult allergy patients reporting adverse reactions to food.
Sonnet, F; Namork, E; Stylianou, E; Gaare-Olstad, I; Huse, K; Andorf, S; Mjaaland, S; Dirven, H; Nygaard, U.
BMC Immunology.
2020;
21.
Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapy.
Wang, W; Lyu, S; Ji, X; Gupta, S; Manohar, M; Dhondalay, GK R; Chinthrajah, S; Andorf, S; Boyd, SD; Tibshirani, R; et al.
Clinical Immunology.
2020;
219:108568-108568.
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study (vol 394, pg 1437, 2019).
Chinthrajah, RS; Purington, N; Andorf, S; Long, A; O'Laughlin, KL; Lyu, SC; Manohar, M; Boyd, SD; Tibshirani, R; Maecker, H; et al.
The Lancet.
2020;
396:380-380.